CEO of the Russian Direct Investment Fund Kirill Dmitriev: Questions on Sputnik V Vaccine Answered, Critics need to Look for Plank in Own Eyes
Leading international scientific journal The Lancet has published the results of the first two stages of clinical trials for the Russian COVID-19 vaccine
The Lancet: Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Sputnik V to lift off for India: Russia will help supply 100 MILLION doses of pioneering coronavirus vaccine to New Delhi
RDIF: Brazil will receive 50 million doses of the Russian Sputnik V coronavirus vaccine by March, and this amount can be doubled
Mexico to Get 32mln Doses of Russian COVID Vaccine, Developers Ready to Make It Available Worldwide
Forbidden Op-ed: the Sputnik Vaccine as a Lifesaving Global Partnership
